ARGXClinical Trials•globenewswire•
argenx Announces Positive Topline Results from ADAPT SERON Study of VYVGART in Patients with AChR-Ab Seronegative gMG
Sentiment:Positive (75)
Summary
August 25, 2025, 7:00 AM CET
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 25, 2025 by globenewswire